Parnate Vs. Lyrica for a male patient aged 49 - from FDA reports


This is a personalized comparison Parnate, Lyrica for a man aged 49. The study is created by eHealthMe based on reports from FDA.



On Jun, 18, 2018

6,071 males aged 49 (±5) who take Parnate, Lyrica are studied.


Number of reports submitted per year:

Parnate, Lyrica for a male patient aged 49.

Information of the patient in this study:

  • Age: 49
  • Gender: male
  • Reason for the study: Anxiety Disorder

Drugs in this study:

  • Parnate (tranylcypromine sulfate)
  • Lyrica (pregabalin)

eHealthMe real world results for males aged 49 (±5):

Comparison with the specified adverse outcomes:
Outcome and its % of total reports:

Edema (excess of watery fluid collecting in the cavities or tissues of the body):
  • Parnate: 0.0 %
  • Lyrica: 1.04 %

Most common side effects:

Parnate:
  1. Abdominal Pain
  2. Aggression
  3. Agitation (state of anxiety or nervous excitement)
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  5. Altered State Of Consciousness (altered state of mind)
Lyrica:
  1. Abdominal Distension
  2. Abdominal Pain
  3. Abdominal Pain Upper
  4. Activities Of Daily Living Impaired
  5. Acute Kidney Failure

Most common side effects experienced by people in long term use:

Parnate:
  1. Aggression
  2. Impatience (restlessness)
  3. Irritability
Lyrica:
  1. Abasia (inability to walk)
  2. Abdominal Discomfort
  3. Abnormal Behavior
  4. Activities Of Daily Living Impaired
  5. Affective Disorder (mental disorder)

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

What are the drugs?

What are the symptoms?

  • Edema (excess of watery fluid collecting in the cavities or tissues of the body) has been reported by people with rheumatoid arthritis, high blood pressure, pain, osteoporosis, multiple sclerosis (latest reports from 45,861 Edema patients).


Related studies:

Related publications that referenced our studies

You may be interested in these posts

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.